- Unilever Indonesia reported a net income of 1.45 trillion rupiah in the first quarter of 2024.
- This represents a 2.8% increase compared to the same period in the previous year.
- Net sales for the quarter were down by 4.9% compared to the previous year, totaling 10.08 trillion rupiah.
- The operating profit increased by 1.3% year-over-year to reach 1.88 trillion rupiah.
- Unilever Indonesia‘s Earnings Per Share (EPS) was 38 rupiah, which exceeded the estimated 32.10 rupiah.
- The company’s shares increased 2.6% to 2,390 rupiah.
- There were a total of 14.6 million shares traded.
- The company currently has 4 buys, 17 holds, and 9 sells.
- All comparisons to past results are based on the company’s original disclosures.
A look at Unilever Indonesia Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
PT Unilever Indonesia Tbk, a leading manufacturer of a wide range of consumer goods including soaps, detergents, margarine, and tea-based beverages among others, is forecasted to have a promising long-term outlook based on Smartkarma Smart Scores. The company’s strong performance in dividend and resilience, with scores of 4 each, signifies stability and potential for consistent returns for investors.
Although Unilever Indonesia scored lower in value and momentum, at 2 each, and moderate in growth at 3, the overall outlook remains positive. With a solid focus on dividends and resilience, coupled with a diverse product portfolio, Unilever Indonesia appears well-positioned to weather market fluctuations and provide steady returns over the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
